Growth in the clinical trial management system market is being driven by digital transformation in pharmaceutical R&D, cloud-deployment trends, demands for real-time oversight, and increasing trial ...
A recent study from Oregon State University estimated that more than 3,500 animal species are at risk of extinction because ...
LAWRENCEVILLE, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that it will ...
Motif ? one of the clinical technology market's fastest-growing companies ? today announced a multi-phase deployment of MotifAI Assistant, its AI-driven automation, across its product portfolio.
Mechelen, Belgium; November 3, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present new and updated data for CAR T-cell therapy candidate, GLPG51011, at the ...
Moderator and GlobalData senior analyst Sonnika Lamont will be joined by Piotr Maslak, senior director and head of emerging ...
Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, presented positive twelve-month clinical data on VisiPlate® Aqueous Shunt from the VITA Trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback